AUPH - Aurinia Pharmaceuticals Inc. (AUPH) CEO Peter Greenleaf on Q4 2021 Results - Earnings Call Transcript
Aurinia Pharmaceuticals Inc. (AUPH) Q4 2021 Earnings Conference Call February 28, 2022 08:30 AM ET Company Participants Dana Lynch - Director of Corporate Communications & Corporate Affairs Peter Greenleaf - President & Chief Executive Officer Joe Miller - Chief Financial Officer Conference Call Participants Alethia Young - Cantor Fitzgerald Maury Raycroft - Jefferies Joseph Schwartz - SVB Securities Stacy Ku - Cowen and Company Ed Arce - H.C. Wainwright David Martin - Bloom Burton Presentation Operator Greetings, and welcome to the Aurinia Pharmaceuticals Fourth Quarter and Full Year 2021 Results Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Dana Lynch, Aurinia's Director of Corporate Communications and Corporate Affairs. Thank you. You may begin. Dana Lynch Thank
For further details see:
Aurinia Pharmaceuticals Inc. (AUPH) CEO Peter Greenleaf on Q4 2021 Results - Earnings Call Transcript